| Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis AC Spyropoulos, C Lipardi, J Xu, C Peluso, TE Spiro, Y De Sanctis, ... TH open 4 (01), e59-e65, 2020 | 169 | 2020 |
| Body mass index, outcomes, and mortality following cardiac surgery in Ontario, Canada AP Johnson, JL Parlow, M Whitehead, J Xu, S Rohland, B Milne Journal of the American Heart Association 4 (7), e002140, 2015 | 114 | 2015 |
| Anesthesia assistance in outpatient colonoscopy and risk of aspiration pneumonia, bowel perforation, and splenic injury B Bielawska, LC Hookey, R Sutradhar, M Whitehead, J Xu, LF Paszat, ... Gastroenterology 154 (1), 77-85. e3, 2018 | 87 | 2018 |
| Improved benefit risk profile of rivaroxaban in a subpopulation of the MAGELLAN study AC Spyropoulos, C Lipardi, J Xu, W Lu, E Suh, Z Yuan, B Levitan, ... Clinical and Applied Thrombosis/Hemostasis 25, 1076029619886022, 2019 | 73 | 2019 |
| Nonparametric cure rate estimation with covariates J Xu, Y Peng Canadian Journal of Statistics 42 (1), 1-17, 2014 | 70 | 2014 |
| Association between asymptomatic proximal deep vein thrombosis and mortality in acutely ill medical patients GE Raskob, AC Spyropoulos, AT Cohen, JI Weitz, W Ageno, Y De Sanctis, ... Journal of the American Heart Association 10 (5), e019459, 2021 | 39 | 2021 |
| An extended cure model and model selection Y Peng, J Xu Lifetime data analysis 18, 215-233, 2012 | 39 | 2012 |
| A rare germline HOXB13 variant contributes to risk of prostate cancer in men of African ancestry BF Darst, R Hughley, A Pfennig, U Hazra, C Fan, P Wan, X Sheng, L Xia, ... European urology 81 (5), 458-462, 2022 | 28 | 2022 |
| Thromboprophylaxis with rivaroxaban in acutely ill medical patients with renal impairment: insights from the MAGELLAN and MARINER trials JI Weitz, GE Raskob, AC Spyropoulos, TE Spiro, Y De Sanctis, J Xu, W Lu, ... Thrombosis and Haemostasis 120 (03), 515-524, 2020 | 27 | 2020 |
| Use of instrumented lumbar spinal surgery for degenerative conditions: trends and costs over time in Ontario, Canada Y Xu, D Yen, M Whitehead, J Xu, AP Johnson Canadian Journal of Surgery 62 (6), 393, 2019 | 16 | 2019 |
| Economies of scale: body mass index and costs of cardiac surgery in Ontario, Canada AP Johnson, JL Parlow, B Milne, M Whitehead, J Xu, S Rohland, ... The European journal of health economics 18, 471-479, 2017 | 15 | 2017 |
| Prevention of venous thromboembolism in hospitalized medically ill patients: a US perspective AC Spyropoulos, W Ageno, AT Cohen, CM Gibson, SZ Goldhaber, ... Thrombosis and Haemostasis 120 (06), 924-936, 2020 | 14 | 2020 |
| Increased risk of death in acutely ill medical patients with asymptomatic proximal deep vein thrombosis or symptomatic venous thromboembolism: insights from the MAGELLAN study GE Raskob, AC Spyropoulos, AT Cohen, JI Weitz, W Ageno, Y De Sanctis, ... Blood 134, 163, 2019 | 9 | 2019 |
| International Consortium for Prostate Cancer Genetics HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer … J Xu, EM Lange, L Lu, SL Zheng, Z Wang, SN Thibodeau, ... Human genetics 132 (1), 5-14, 2013 | 9 | 2013 |
| Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study S Opat, A Tedeschi, B Hu, KM Linton, P McKay, S Leitch, M Coleman, ... Blood Advances 7 (22), 6801-6811, 2023 | 6 | 2023 |
| Long-term efficacy and safety of zanubrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): final analysis of the MAGNOLIA (BGB-3111-214) trial S Opat, A Tedeschi, B Hu, KM Linton, P McKay, H Chan, J Jin, M Sun, ... Blood 140 (Supplement 1), 573-576, 2022 | 6 | 2022 |
| Surgery for diverticular disease results in a higher hernia rate compared to colorectal cancer: a population-based study from Ontario, Canada ES Tang, DI Robertson, M Whitehead, J Xu, SF Hall Hernia 22, 603-609, 2018 | 6 | 2018 |
| Assessing the cumulative contribution of new and established common genetic risk factors to early-onset prostate cancer EM Lange, JV Ribado, KA Zuhlke, AM Johnson, GR Keele, J Li, Y Wang, ... Cancer Epidemiology, Biomarkers & Prevention 25 (5), 766-772, 2016 | 6 | 2016 |
| Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended Thromboprophylaxis. TH Open … AC Spyropoulos, C Lipardi, J Xu, C Peluso, TE Spiro, Y De Sanctis | 4 | 2020 |
| Risk of severe bleeding with extended rivaroxaban to prevent venous thromboembolism in acute medically ill patients with bronchiectasis C Lipardi, CG Elliott, CL Sugarmann, L Haskell, AC Spyropoulos, ... Clinical and Applied Thrombosis/Hemostasis 27, 10760296211053316, 2021 | 3 | 2021 |
